Bracco Gains FDA Clearance for VueJect Cardiac Imaging System
MILAN, Italy, August 11, 2026 Bracco Imaging has announced that its VueJect® ultrasound contrast delivery system has received 510(k)...
Gastroenterology
Advertisement
Alfasigma to Acquire Nordic Pharma in European M&A Deal
BOLOGNA AND MILAN, Italy, August 13, 2026 Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life...
Aqua Medical Appoints Bob Haggerty to Lead Diabetes Growth
Pleasanton, California, August 4, 2026 Aqua Medical, Inc. has announced the appointment of Robert “Bob” Haggerty as President and...
CalciMedica Aligns With FDA on Auxora Phase 2b Trial
LA JOLLA, Calif., July 29, 2026 CalciMedica, Inc. has announced a significant regulatory milestone after reaching alignment with the...
FlyteHealth Expands Medicare Care Through CMS Platform
NEW CANAAN, Conn., July 28, 2026 FlyteHealth has achieved General Availability within the Centers for Medicare & Medicaid Services...
Advertisements
Aqua Medical Treats First U.S. Patient in Diabetes Trial
PLEASANTON, Calif., July 28, 2026 Aqua Medical, Inc. has achieved a major clinical milestone with the successful treatment of...
Palisade Bio Receives FDA IND Clearance for PALI-2108
DENVER, Colo., June 29, 2026 Palisade Bio, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared...
Belay Announces NCCN Recommendation for CSF-Based Profiling in High-Grade Gliomas
CHICAGO, Ill., June 20, 2026 The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines in Oncology...
cAMPfield Launches With $180M to Advance Oral IBD Therapy
SAN DIEGO, Calif., June 20, 2026 cAMPfield Therapeutics has officially emerged from stealth with a $180 million Series A...
Edgewise Reports Positive Phase 2 EDG-7500 HCM Data
BOULDER, Colo., June 16, 2026 Edgewise Therapeutics has announced positive top-line results from the 12-week Phase 2 CIRRUS-HCM trial...
Advertisement
